These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 413937

  • 1. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT, Daly JJ, Heaney JA, Heney NM, Prout GR.
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin.
    Horn Y, Eidelman A, Walach N, Yuval E, Markowitz A.
    J Surg Oncol; 1984 Sep; 27(1):67-9. PubMed ID: 6434883
    [Abstract] [Full Text] [Related]

  • 6. Morphologic effects of thio-TEPA on mouse urothelium.
    Murphy WM, Soloway MS, Lin CJ.
    Acta Cytol; 1977 Sep; 21(5):701-4. PubMed ID: 414498
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.
    Hirao Y, Okajima E, Ozono S, Samma S, Sasaki K, Hiramatsu T, Babaya K, Watanabe S, Maruyama Y.
    Cancer Chemother Pharmacol; 1992 Sep; 30 Suppl():S26-30. PubMed ID: 1394812
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW, Prout GR, Smith W, Frable WJ, Minnis JE.
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anticancer drug sensitivity in vitro in the bladder cancer cell line, KK-47 and prophylactic use of carbazilquinone and urokinase in bladder cancer.
    Hisazumi H, Uchibayashi T, Katoh M, Kobayashi T, Nakajima K, Naitoh K, Misaki T, Kuroda K.
    Urol Res; 1981 Mar; 9(5):231-5. PubMed ID: 7029855
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.